Dataset supports machine learning and deep learning for maternal health risk prediction, indicating high accuracy for clinical decision-making.
This data article presents a comprehensive maternal health risk dataset comprising 6058 samples (from an initially collected 6103 samples, after quality validation and outlier removal) collected through Internet of Things (IoT)-enabled Medical Cyber-Physical Systems (MCPS) across nine healthcare facilities in Bangladesh between February 2021 and January 2023. The dataset includes eight clinical features: age, body temperature, heart rate, systolic and diastolic blood pressure, body mass index (BMI), hemoglobin A1c (HbA1c), and fasting blood glucose levels, with expert- validated three-level risk classifications (high, mid, low). Data collection employed standardized IoT sensors with Raspberry Pi 4 controllers and medical-grade sensor arrays. Comprehensive quality validation removed 45 physio- logically implausible samples (0.74%), ensuring all values fall within clinically acceptable ranges. Comprehensive evaluation demonstrates dual-purpose utility(1) immediate clinical deployment for hos- pital decision support systems and (2) research baseline infrastructure for future temporal modeling studies-validated through rigorous experimental analysis. Traditional machine learning models achieved clinical-grade performance (defined as ≥95% accuracy with balanced precision/recall, consistent with established clinical decision support benchmarks), with XGBoost and Random Forest both reaching 99.34% accuracy (95% confidence interval: 98.84–99.75%), confirming exceptional data quality for immediate clinical deployment in hospital decision support systems. Feature importance analysis identified diastolic blood pressure (18.1%), body temperature (17.7%), and systolic blood pres- sure (17.0%) as primary predictive indicators. Additionally, recurrent neural network (RNN) models achieved 93.98% accuracy using synthetic temporal sequences (treating features as timesteps), establishing architectural baselines for future longitudinal studies. The 5.36% performance gap between XGBoost and Simple RNN ( p < 0.001, McNemar’s test) confirms the dataset’s cross-sectional structure is optimally suited for ensemble learning methods, while RNN experiments provide proof-of-concept infrastructure for temporal modeling when genuine longitudinal measurements become available. This dataset addresses the critical need for maternal health risk prediction in resource-limited set- tings, supporting both immediate clinical deployment and future research directions. The data demonstrate readiness for integration into clinical decision support systems (validated by 99.34% accuracy), temporal modeling research infrastructure (93.98% RNN baseline), and healthcare technology development. All data underwent rigorous quality control with physiologically validated ranges, expert risk classification, and ethical approval (DUET-IRB-2021–034), making it suitable for academic research, clinical implementation, and public health policy formulation in developing countries.
No takes yet. Share an insight, caveat, or question.
Hossain et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: